Applications of (E)-3-[2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolinyl]-2-Propenenitrile in Industrial Manufacturing

As a specialized manufacturer of (E)-3-[2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolinyl]-2-Propenenitrile, we supply this molecule for defined industrial sectors that rely on its unique structural characteristics, stability, and compatibility with precision process requirements. Below are the core downstream manufacturing scenarios where this compound integrates into advanced formulations, ranging from pharmaceuticals to crop protection agents, focusing on the actual, validated pathways adopted by our industry clients.

1. Active Pharmaceutical Ingredient (API) Intermediate Synthesis

Our material is commonly adopted by pharmaceutical producers as a critical intermediate in the multi-step synthesis of quinoline-based APIs, especially for targeted therapies related to oncological or anti-infective indications. This compound participates in the selective construction of heterocyclic core structures demanding stability under varied process conditions, and meets the purity thresholds necessary for use in regulated manufacturing environments.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP; 21 CFR Parts 210 & 211, US FDA)
• European Pharmacopoeia (Ph. Eur.) guidelines for intermediate management
• International Conference on Harmonisation Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• ICH Q3A/B: Impurities in New Drug Substances/Products

Typical usage ratio

• Ranges from 0.2 to 1.0 mole equivalent per batch depending on desired API yield and required functionalization; the ratio is adjusted according to reaction scale and target compound structure.

Downstream process integration

• Introduced as a late-stage intermediate during heterocycle assembly via palladium-catalyzed coupling or nucleophilic substitution, following substrate activation and prior to purification.

Final product types

• Targeted small-molecule cancer therapeutics
• Antiviral pharmaceutical compounds
• Research-grade API standards for clinical development
• Regulated finished drug substances for injectable and oral formulations

2. Crop Protection Active Ingredient Development

Agrichemical formulators frequently utilize this compound as a building block for the synthesis of new-generation active substances targeting resistance management in pest control. Its rigid fused ring and halogenated structure enable the creation of molecules with high target specificity and environmental stability during agrochemical active ingredient invention and commercial manufacturing.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals (Agricultural Chemicals)
• FAO/WHO Specifications for Plant Protection Products
• ISO 9001:2015 Quality Management System for agrochemical production
• REACH Regulation (EC No 1907/2006) for registration and classification

Typical usage ratio

• 0.5–2.0% by weight of total synthetic batch, subject to downstream reaction requirements and regulatory impurity limits; proportion is scaled to maintain target active concentration in final technical concentrate.

Downstream process integration

• Inserted during pre-condensation or cyclization steps of agrochemical active ingredient synthesis; often coupled with sulfonation, alkylation, or halogenation stages preceding formulation into technical grade concentrates.

Final product types

• Technical grade insecticidal or fungicidal actives
• Pre-mix intermediates for post-patent crop protection products
• Chemical standards for pesticide residue monitoring
• Registration samples for regulatory submission

3. Specialty Fine Chemical Synthesis for Electronic Materials

Manufacturers of organic electronic materials use this compound in the fine chemical synthesis pathways required for creating charge-transporting agents and functional coatings. The electronic properties of its quinoline-fluorophenyl motif prove essential for achieving controlled conduction and emission in the optimized production of photoluminescent or semiconducting organic layers.

Industry compliance standards

• IEC 62321:2017 Determination of certain substances in electrotechnical products
• RoHS Directive 2011/65/EU Annex II compliance for hazardous substance levels
• ISO/TS 80004-8:2013 (Nanotechnologies—Nanomanufacturing processes)
• Supplier-approved internal QC protocols for optoelectronic purity

Typical usage ratio

• 0.1–0.7 molar ratio in the functional monomer feed, adjusted to achieve specific electrical activity in polymer backbone; process optimization determined by emission spectrum and film uniformity requirements.

Downstream process integration

• Added during active monomer synthesis to incorporate the functional moiety prior to controlled polymerization or coupling; typically introduced before vacuum deposition or spin-coating stages in device fabrication.

Final product types

• OLED emitter materials
• Organic semiconductor films for thin-film transistors
• Photoluminescent layers in display modules
• Precursor chemicals for printed electronics production

4. Research and Analytical Reference Standard Preparation

Analytical laboratories and reference standard producers require this high-purity compound for developing certified reference substances and calibration materials, especially in method validation for pharmaceutical, environmental, and forensic residue analysis. Its defined structure provides a reliable marker in quantitative and qualitative analytical workflows.

Industry compliance standards

• ISO 17034:2016 General requirements for the competence of reference material producers
• USP <1045> Analytical Instrument Qualification
• ISO/IEC 17025:2017 for ISO-compliant analytical laboratories
• FDA Guidance for Industry: Analytical Procedures and Methods Validation for Drugs

Typical usage ratio

• Prepared as 0.1–10 ppm stock solutions in suitable solvent or matrix; the concentration is set according to specific instrument sensitivity and lower limit of quantification.

Downstream process integration

• Processed through recrystallization or chromatography to assure purity, then packaged and certified; material is directly implemented as a primary or secondary standard for developing and calibrating analytical methods.

Final product types

• Certified pharmaceutical reference standards
• Analytical calibration solutions for LC-MS or GC-MS
• Laboratory quality control materials
• Reference substances for regulatory assay validation